The failure to follow good manufacturing practices leads to product defects, contamination, and other problems that put patients at risk.
List of drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death." Check the dashboards for the most recent shortages, or at the complete PDF list, updated every week.
Get Resilient Drug Supply updates in your inbox.
The European Union (EU) Commission plans to publish a draft of the largest overhaul of medical laws in 20 years.
Three of five US makers report shortages, which result from increased demand and manufacturing delays.
From 2021 to 2022, new drug shortages rose by nearly 30%, with the average shortage lasting 1.5 years.
Injectable methotrexate, cisplatin, fluorouracil, and Pluvicto are in shortage, with no definitive end in sight.
There is no cheap alternative to liquid albuterol, which is used in nebulizers to treat children too young to use an inhaler.
Chinese export of active pharmaceutical ingredients has been complicated by pandemic-related supply-chain chaos and, more recently, the lifting of the country's zero-COVID policy.
The lawmakers say that while the shortages have eased, supplies haven't been completely replenished.
Alternatives to Bacillus Calmette-Guerin are tied to many negative consequences, including adverse effects and premature organ loss.
Experts fear the incident could hamper the US-China medical supply chain, including upending FDA regulatory inspections.
The shortage is leading to delays in the testing of deer samples submitted by hunters.
